A Study to Evaluate the Pharmacokinetic Interaction and the Safety of AD-236A and AD-236B
A Study to Evaluate the Pharmacokinetic Interaction and the Safety of AD-236A and AD-236B
Not yet recruiting · NCT07730567 · Registry updated 2026-07-28Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Pharmacokinetic Interaction and the Safety of AD-236A and AD-236B | Dyslipidemias, Lipid Metabolism Disorders, Nutritional and Metabolic Diseases, diabetes mellitus, endocrine system disorder, glucose metabolism disease, hyperlipidemia, metabolic disease, type 2 diabetes mellitus | Not yet recruiting | Phase 1 | 2026-07-28 | NCT07730567 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Addpharma Inc. | 24 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| H+ Yangji Hospital, Seoul, | Seoul | South Korea | 1 |